[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

JPH0959166A - Epithelial cell proliferation promoter - Google Patents

Epithelial cell proliferation promoter

Info

Publication number
JPH0959166A
JPH0959166A JP7230682A JP23068295A JPH0959166A JP H0959166 A JPH0959166 A JP H0959166A JP 7230682 A JP7230682 A JP 7230682A JP 23068295 A JP23068295 A JP 23068295A JP H0959166 A JPH0959166 A JP H0959166A
Authority
JP
Japan
Prior art keywords
skin
glycoside
malonyl
water
soybeans
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP7230682A
Other languages
Japanese (ja)
Other versions
JP3302535B2 (en
Inventor
Masaru Matsuura
勝 松浦
Minoru Saito
實 斉藤
Akio Obata
明雄 小幡
Nobuyuki Yamatsugu
信幸 山次
Kouichirou Tobe
光一朗 戸辺
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NODA SANGYO KAGAKU KENKYUSHO
Kikkoman Corp
Original Assignee
NODA SANGYO KAGAKU KENKYUSHO
Kikkoman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NODA SANGYO KAGAKU KENKYUSHO, Kikkoman Corp filed Critical NODA SANGYO KAGAKU KENKYUSHO
Priority to JP23068295A priority Critical patent/JP3302535B2/en
Publication of JPH0959166A publication Critical patent/JPH0959166A/en
Application granted granted Critical
Publication of JP3302535B2 publication Critical patent/JP3302535B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)

Abstract

PROBLEM TO BE SOLVED: To obtain an epithelial cell proliferation promoter, a skin cosmetic, a hair tonic, a skin preparation for external use, etc., having multiplying effect on epithelial cell, comprising malonylisoflavone glycoside as an active ingredient. SOLUTION: This epithelial cell proliferation promoter comprises malonylisoflavone glycoside as an active ingredient. The glycoside is obtained from soybeans or an extracted solution of soybeans with water and, for example, malonyldaizin etc., are preferably used. The glycoside, for example, is obtained by immersing peeled soybeans in water adjusted to pH7.5 to pH9.0 with caustic soda, etc., at 45-65 deg.C for 2-4 hours, removing the soybeans to give the immersion water as an extracted solution with water, removing protein from the extracted solution by an ultrafilter membrane to give a filtrate, bringing the filtrate into contact with an adsorbent and eluting the glycoside from the adsorbed material by using an aqueous solution of an alcohol or an alkali aqueous solution of an alcohol.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明はマロニルイソフラボン配
糖体を上皮細胞増殖因子として含有させた、新規な上皮
細胞増殖促進剤ないし皮膚用剤に関するものである。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a novel epithelial cell growth promoter or dermatological agent containing malonyl isoflavone glycoside as an epidermal growth factor.

【0002】[0002]

【従来の技術及び課題】最近皮膚の細胞成長因子、例え
ば上皮成長因子(EGF)、線維芽細胞成長因子(FG
F)等が発見され、これらの成長因子を利用して、皮膚
の老化防止を目的とする皮膚化粧料や、皮膚の創傷治癒
期間の短縮を目的とする皮膚外用剤が開発されている。
例えばグルコサミノグリカンと線維芽細胞成長因子とを
配合した皮膚化粧料(特開平4−187613)、α−
ヒドロキシ酢酸を配合した皮膚化粧料及び皮膚外用剤
(特開平5−112422)、カバノキ科植物の抽出エ
キスを含有させた皮膚老化防止化粧料(特開平6−26
3627)等を挙げることができる。
2. Description of the Related Art Recently, skin cell growth factors such as epidermal growth factor (EGF) and fibroblast growth factor (FG) have been developed.
F) and the like were discovered, and by utilizing these growth factors, skin cosmetics for the purpose of preventing skin aging and skin external preparations for the purpose of shortening the skin wound healing period have been developed.
For example, skin cosmetics containing glucosaminoglycan and fibroblast growth factor (JP-A-4-187613), α-
Skin cosmetics and external preparations for skin containing hydroxyacetic acid (JP-A-5-112422), and skin anti-aging cosmetics containing an extract of birch plants (JP-A-6-26).
3627) and the like.

【0003】一方大豆のイソフラボン化合物は、エステ
ロゲン作用、抗酸化作用、抗溶血作用、抗コレステロー
ル作用、抗脂血作用、抗菌作用等、種々の生理作用を有
することが知られており、これらの生理作用を利用した
皮膚化粧料等に関する特許出願もなされており、例えば
大豆イソフラボン化合物含有美白化粧料(特公昭60−
19885)、大豆サポニン含有化粧料組成物(特開昭
59−106419)、大豆胚軸の水抽出物を有効成分
とする保湿剤(特開昭63−243013)等が知られ
ている。また最近になって、大豆中にはマロニルダイジ
ン及びマロニルゲニスチン等のマロニルイソフラボン配
糖体の存在が確認され、これらが大豆中のイソフラボン
化合物の主成分であることが判ってきた。このマロニル
イソフラボン配糖体は水に溶け易く、またそれ自身抗酸
化作用があり、またその構造の類似性から上記したよう
な薬理効果が期待されている。
On the other hand, isoflavone compounds of soybean are known to have various physiological actions such as an estrogen action, an antioxidant action, an antihemolytic action, an anticholesterol action, an antilipemic action and an antibacterial action. A patent application relating to skin cosmetics and the like utilizing the action has been made, for example, a whitening cosmetic containing a soy isoflavone compound (Japanese Patent Publication No. 60-
19885), a soybean saponin-containing cosmetic composition (JP-A-59-106419), a moisturizer containing an aqueous extract of soybean hypocotyl as an active ingredient (JP-A-63-243013), and the like are known. Moreover, the presence of malonyl isoflavone glycosides such as malonyl daidzin and malonyl genistin has been recently confirmed in soybean, and it has been found that these are the main components of the isoflavone compound in soybean. This malonyl isoflavone glycoside is easily soluble in water, has an antioxidant effect by itself, and is expected to have the above-mentioned pharmacological effects due to its structural similarity.

【0004】本発明者等は先に、大豆の水抽出液そのも
のが皮膚外用剤として効果のあることを見い出し特許出
願した(特願平6−305697)が、さらに検討を進
めた結果、大豆の水抽出液中にはマロニルイソフラボン
配糖体が含有されており、抽出液を吸着剤に接触さ
せ、、次いでアルコール水溶液で溶出させることにより
マロニルイソフラボン配糖体が簡単に取得できるという
知見を得、特許出願した(特願平7−112705)。
そして更に、このマロニルイソフラボン配糖体が上皮細
胞の増殖に効果のあることを見い出した。
The present inventors previously found that the water extract of soybean itself was effective as an external preparation for skin, and filed a patent application (Japanese Patent Application No. 6-305697). Malonyl isoflavone glycosides are contained in the water extract, and the finding that malonyl isoflavone glycosides can be easily obtained by contacting the extract with an adsorbent and then eluting with an aqueous alcohol solution, We applied for a patent (Japanese Patent Application No. 7-112705).
Furthermore, they have found that this malonyl isoflavone glycoside has an effect on the proliferation of epithelial cells.

【0005】[0005]

【課題を解決するための手段】本発明はこのような知見
に基づきなされたものであって、上皮細胞増殖因子とし
てマロニルイソフラボン配糖体を含有させた皮膚用剤で
ある。以下本発明を具体的に説明する。
The present invention has been made based on such findings, and is a dermatological agent containing malonyl isoflavone glycoside as an epidermal growth factor. Hereinafter, the present invention will be described specifically.

【0006】<マロニルイソフラボン配糖体の取得>大
豆中のマロニルダイジン
<Acquisition of Malonyl Isoflavone Glycoside> Malonyl daidzin in soybean

【化1】 マロニルゲニスチンEmbedded image Malonyl genistin

【化2】 等のマロニルイソフラボン配糖体の含量は、大豆の種
類、収穫時期等によってことなるが、文献{J.Agric.Fo
od Chem.,42,1674(1994)}によれば表1の通りである。
なお含量は大豆1gあたりのマイクログラムである。 表1 大豆(年度) マロニルダイジン マロニルゲニスチン アメリカ種 Vinton81(1989) 410 958 Vinton81(1990) 300 743 Vinton81(1991) 237 545 Pioneer9111(1989) 690 1756 Pioneer9202(1989) 630 1705 Prize(1989) 709 1342 HP204(1989) 345 915 LS301(1989) 752 1558 KL72(1989) 198 1042 Strayer2233(1989) 385 883 日本種 Keburi(1991) 562 1232 Keburi(1992) 322 670 Kuro daizu(1991) 375 1187 Kuro daizu(1992) 222 717 Raiden(1991) 407 1191 Raiden(1992) 242 723
Embedded image The content of malonyl isoflavone glycosides, etc., varies depending on the type of soybean, the harvest time, etc., but the literature {J. Agric.
od Chem., 42, 1674 (1994)}.
The content is microgram per 1 g of soybean. Table 1 Soybean (FY) Malonyldaidine Malonylgenistin American Varieties Vinton81 (1989) 410 958 Vinton81 (1990) 300 743 Vinton81 (1991) 237 545 Pioneer9111 (1989) 690 1756 Pioneer9202 (1989) 630 1705 Prize (1989) 709 1342 HP204 ( 1989) 345 915 LS301 (1989) 752 1558 KL72 (1989) 198 1042 Strayer2233 (1989) 385 883 Japanese species Keburi (1991) 562 1232 Keburi (1992) 322 670 Kuro daizu (1991) 375 1187 Kuro daizu (1992) 222 717 Raiden (1991) 407 1191 Raiden (1992) 242 723

【0007】大豆からマロニルイソフラボン配糖体を製
造する方法としては特開平3-170495号に記載されている
ように、粉砕大豆をアルコール抽出したのち、その抽出
物を数段の水不混和性有機溶媒で抽出処理して製造する
方法が知られているが製造方法の容易性、収率の点から
以下に記載の如く、大豆の水抽出液から取得する方法が
好ましい。
As a method for producing malonyl isoflavone glycosides from soybeans, as described in JP-A-3-170495, ground soybeans are subjected to alcohol extraction, and then the extract is subjected to several stages of water-immiscible organic compounds. Although a method of producing by extracting with a solvent is known, a method of obtaining from a water extract of soybean is preferable as described below from the viewpoint of ease of production and yield.

【0008】すなわちマロニルイソフラボン配糖体を得
るための原料は、丸大豆、脱皮大豆、脱脂大豆等であ
り、これらの水抽出液が好適に用いられる。例えば丸大
豆、脱皮大豆あるいは脱脂大豆を20〜80℃の水に1
〜30時間浸漬して得られる抽出液であるが、中でも脱
皮大豆や脱脂大豆が好適である。もちろん、醤油、味
噌、豆腐、納豆、豆乳、或いはもやしの製造に際して生
ずる大豆の浸漬廃液も有効に利用できる。また大豆煮汁
や木綿豆腐製造において生じるホエーも利用可能であ
る。そして大豆の水抽出液を得るのに好ましい態様とし
ては、脱皮大豆を、カセイソーダ等によりpH10.0以
下、好ましくは7.5〜9.0に調整した45〜65℃
の水に2〜4時間浸漬し、浸漬大豆を除いて得られる浸
漬水を水抽出液とする。
That is, the raw materials for obtaining malonyl isoflavone glycosides are whole soybeans, dehulled soybeans, defatted soybeans, etc., and their water extracts are preferably used. For example, add whole soybeans, dehulled soybeans or defatted soybeans to water at 20-80 ° C.
It is an extract obtained by soaking for about 30 hours, and among them, dehulled soybeans and defatted soybeans are preferable. Of course, soy sauce, miso, tofu, natto, soy milk, or soybean dipping waste liquid generated during the production of sprouts can also be effectively used. Also, whey produced in soybean juice and cotton tofu production can be used. And as a preferred embodiment for obtaining the water extract of soybean, the dehulled soybean is adjusted to pH 10.0 or less by caustic soda or the like, preferably 45 to 65 ° C., which is adjusted to 7.5 to 9.0.
The soaked water obtained by removing the soaked soybeans is used as a water extract.

【0009】この場合、浸漬水のpHを10.0以上にす
るとマロニルイソフラボン配糖体の収率が低下する。こ
れはマロニルイソフラボン配糖体が分解し、イソフラボ
ン配糖体となるためである。また大豆成分の抽出率を上
げるためには、浸漬温度は高いほうが有利であるが、7
0℃以上にするとマロニルイソフラボン配糖体が分解し
はじめる。したがって抽出率と分解率とを考慮すると4
5〜65℃が適当である。
In this case, the yield of malonyl isoflavone glycoside decreases when the pH of the immersion water is set to 10.0 or higher. This is because malonyl isoflavone glycosides are decomposed into isoflavone glycosides. In order to increase the extraction rate of soybean ingredients, it is advantageous to use a higher soaking temperature.
Malonyl isoflavone glycosides begin to decompose at temperatures above 0 ° C. Therefore, considering the extraction rate and the decomposition rate, 4
A temperature of 5 to 65 ° C is suitable.

【0010】また脱脂大豆を使用する場合の脱脂大豆は
低変性脱脂大豆が好適であり、これを直接水に浸漬し、
抽出するか、低変性脱脂大豆の粉砕物を水又はアルカリ
水で抽出し、不溶残渣を除去したのち抽出液を塩酸でpH
4.3付近で酸沈して得られる分離大豆蛋白を除いた
液、すなわち大豆ホエーでもよい。
When defatted soybeans are used, the defatted soybeans are preferably low-denaturation defatted soybeans, which are directly immersed in water,
Extract or pulverize low-denaturing defatted soybeans with water or alkaline water to remove insoluble residues, and then add the extract to pH with hydrochloric acid.
A liquid obtained by removing precipitated soybean protein obtained by acid precipitation in the vicinity of 4.3, that is, soybean whey may be used.

【0011】このような大豆の抽出液を必要により限外
濾過膜を用いて蛋白質を除去した濾液、あるいは上記大
豆ホエーのように塩酸でpH4.3程度に調整し、抽出液
中に溶解している蛋白質を沈澱させ、その上澄液を吸着
剤に接触させる。上記濾液あるいは上澄液は、そのまま
吸着剤と接触させる方法と、濾液あるいは上澄液をカセ
イソーダでpH8.0程度に調整した後接触させる方法と
がある。
If necessary, the soybean extract is filtered to remove protein using an ultrafiltration membrane, or the soybean whey is adjusted to about pH 4.3 with hydrochloric acid and dissolved in the extract. The proteins present are allowed to settle and the supernatant is contacted with the adsorbent. The above-mentioned filtrate or supernatant may be contacted with the adsorbent as it is, or the filtrate or supernatant may be adjusted to pH 8.0 with caustic soda and then contacted.

【0012】前者の場合は吸着剤に対する吸着量が増大
し、後者の場合はマロニルイソフラボン配糖体とイソフ
ラボン配糖体及びアグリコンの分離が容易であるという
利点がある。いずれの場合でも、使用する吸着剤は、例
えば合成吸着剤、活性炭、アルミナ等であり、具体的に
はダイヤイオンHP-20(三菱化学製)、精製白鷺活性炭
(武田薬品工業製)、活性アルミナ(和光純薬製)等を
挙げることができる。接触はバッチ法、カラム法等一般
的方法でよく、例えば、吸着剤を充填したカラムに抽出
液を通過させることにより行うことができ、こうするこ
とにより抽出液中のマロニルイソフラボン配糖体の殆ど
が吸着剤に吸着される。
In the former case, the amount of adsorption to the adsorbent is increased, and in the latter case, there is an advantage that the malonyl isoflavone glycoside, the isoflavone glycoside and the aglycone can be easily separated. In any case, the adsorbent used is, for example, a synthetic adsorbent, activated carbon, alumina or the like, and specifically, Diaion HP-20 (manufactured by Mitsubishi Chemical), purified Shirasagi activated carbon (manufactured by Takeda Chemical Industries), activated alumina. (Manufactured by Wako Pure Chemical Industries, Ltd.) and the like. The contact may be carried out by a general method such as a batch method or a column method. For example, the extraction solution may be passed through a column packed with an adsorbent, whereby almost all malonyl isoflavone glycosides in the extraction solution may be contacted. Are adsorbed by the adsorbent.

【0013】次いで吸着剤に吸着したマロニルイソフラ
ボン配糖体をアルコール水溶液又はアルカリ性アルコー
ル水溶液を用いて、マロニルイソフラボン配糖体を溶出
させる。得られた溶液は減圧濃縮し、あるいは減圧濃縮
後、凍結乾燥してマロニルイソフラボン配糖体の乾燥粉
末を得る。
Then, the malonyl isoflavone glycoside adsorbed on the adsorbent is eluted with an aqueous alcohol solution or an alkaline alcohol aqueous solution. The obtained solution is concentrated under reduced pressure, or concentrated under reduced pressure and then freeze-dried to obtain a dry powder of malonyl isoflavone glycoside.

【0014】上記濃縮液あるいは乾燥粉末はマロニルダ
イジン及びマロニルゲニスチンの混合物であり、これを
分別して取得する場合には、逆相クロマトグラフィーに
より分取することができる。例えばODS樹脂(山村化
学製)を充填したカラムに濃縮液を通液し、マロニルイ
ソフラボン配糖体を吸着させ、アルコール水溶液で溶出
してマロニルダイジン、マロニルゲニスチンを分画し、
これらの画分を減圧濃縮後、凍結乾燥してマロニルダイ
ジン及びマロニルゲニスチンの乾燥粉末を得る。
The above concentrated liquid or dry powder is a mixture of malonyl daidzin and malonyl genistin, and when it is obtained by fractionation, it can be fractionated by reverse phase chromatography. For example, a concentrated liquid is passed through a column filled with ODS resin (manufactured by Yamamura Chemical Co., Ltd.) to adsorb malonyl isoflavone glycoside, and eluted with an aqueous alcohol solution to fractionate malonyl daidzin and malonyl genistin,
These fractions are concentrated under reduced pressure and then freeze-dried to obtain a dry powder of malonyldaididine and malonylgenistin.

【0015】なお、マロニルダイジン及びマロニルゲニ
スチンを効率よく得るためには以下の方法によることが
好ましい。すなわち大豆の抽出液を吸着剤と接触させる
までは上記と同様であるが、溶出をアルコール水溶液の
濃度を変えて順次行い、大まかにマロニルダイジンとマ
ロニルゲニスチンを分別しこれらの溶出液をODSカラ
ムで精製するのである。このようにして大豆の抽出液よ
り簡単にマロニルイソフラボン配糖体、あるいはマロニ
ルダイジン及びマロニルゲニスチンを分別して得ること
ができる。
In order to efficiently obtain malonyl daidzin and malonyl genistin, the following method is preferable. That is, the above is the same as above until the soybean extract is brought into contact with the adsorbent, but the elution is sequentially performed by changing the concentration of the alcohol aqueous solution, and the malonyldaididine and the malonylgenistin are roughly separated and these eluates are separated by an ODS column. Purify. In this way, malonyl isoflavone glycosides or malonyl daidzin and malonyl genistin can be easily separated and obtained from the soybean extract.

【0016】このようにして得られたマロニルイソフラ
ボン配糖体は、上皮細胞を増殖させる効果を有し、これ
を通常用いられる各種基剤、例えば油分、界面活性剤、
保湿剤、アルコール、増粘剤、香料、酸化防止剤、キレ
ート剤、色素、防腐剤等に配合することにより、上皮細
胞増殖促進剤、皮膚化粧剤、育毛剤、皮膚外用剤、抗炎
症剤等の皮膚用剤とすることができる。マロニルダイジ
ン、マロニルゲニスチンの配合量は、皮膚外用剤、皮膚
化粧剤、抗炎症剤いずれの場合でも0.001〜100
0ppmである。また他の上皮細胞増殖因子との併用も
できる。
The malonyl isoflavone glycoside thus obtained has the effect of proliferating epithelial cells, and various bases usually used such as oil, surfactant,
By blending with moisturizers, alcohols, thickeners, fragrances, antioxidants, chelating agents, pigments, preservatives, etc., epithelial cell growth promoters, skin cosmetics, hair growth agents, skin external preparations, anti-inflammatory agents, etc. It can be used as a skin preparation. The amount of malonyl daidzin and malonyl genistin used is 0.001 to 100 for any of the skin external preparations, skin cosmetics, and anti-inflammatory agents.
It is 0 ppm. It can also be used in combination with other epidermal growth factors.

【0017】次にマロニルイソフラボン配糖体の上皮細
胞増殖効果について検討した結果を示す。なお使用した
細胞は、米国白人皮膚由来の正常ヒト皮膚上皮細胞(No
rmal human epidermal keratinocyte:NHEK)(倉敷紡績
株式会社扱い)である。
Next, the results of examining the epithelial cell growth effect of malonyl isoflavone glycoside will be shown. The cells used were normal human skin epithelial cells (No.
rmal human epidermal keratinocyte (NHEK) (handled by Kurashiki Spinning Co., Ltd.).

【0018】使用培地:改変MCDB153培地(倉敷
紡績製)にヒト組み換え型上皮成長因子(hEGF)を
O.1ng/ml、インスリンを5μg/ml、ハイド
ロコーチゾンを0.5μg/ml、抗菌剤としてゲンタ
マイシンを50μg/ml、アンフォテンシンを0.0
5μg/mlを添加し、表皮角化細胞増殖用培地(K−
DM)とした。
Medium used: Modified MCDB153 medium (manufactured by Kurashiki Spinning Co., Ltd.) was supplemented with human recombinant epidermal growth factor (hEGF). 1 ng / ml, insulin 5 μg / ml, hydrocortisone 0.5 μg / ml, gentamicin 50 μg / ml as antibacterial agent, amphotensin 0.0
5 μg / ml was added to the medium for growing epidermal keratinocytes (K-
DM).

【0019】培養方法:正常ヒト皮膚上皮細胞(NHEK)
を上記K−DM培地に5000cells/mlとなるように
懸濁し、48wellプレート(住友ベークライト製)
に0.3ml/wellとなるように接種し、これを5
%CO2と95%空気の雰囲気下、37℃、湿度100
%の培養機内で4時間培養する。培養後、表2に示す試
料液を10μl添加し、更に72時間培養後、K−DM
培地を除去し、新たに新鮮なK−DM培地を0.3ml
/wellと試料を再添加し、72時間培養し、細胞の
増殖を測定した。
Culture method: Normal human skin epithelial cells (NHEK)
Suspended in the above K-DM medium at 5000 cells / ml, and a 48-well plate (Sumitomo Bakelite)
To 0.3 ml / well, and inoculate this to 5
% CO 2 and 95% air atmosphere, 37 ℃, humidity 100
% Incubator for 4 hours. After culturing, 10 μl of the sample solution shown in Table 2 was added, and after culturing for 72 hours, K-DM was added.
Remove the medium and add 0.3 ml of fresh K-DM medium.
/ Well and the sample were re-added and cultured for 72 hours, and the proliferation of cells was measured.

【0020】細胞増殖の測定:和光純薬工業製のCel
l Counting Kit{(WST−1:2-(4-I
odophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl-
2H-tetrazolium,monosodium salt}を使用し、発色反応
させ、分光光度計で波長***での吸光度(OD)を測
定した。本測定方法は吸光度と細胞数は直線的な比例関
係にある。なお比較2〜4は水に難溶性であるので溶解
限度の濃度で実験を行なった。
Measurement of cell proliferation: Cel manufactured by Wako Pure Chemical Industries
l Counting Kit {(WST-1: 2- (4-I
odophenyl) -3- (4-nitrophenyl) -5- (2,4-disulfophenyl-
2H-tetrazolium, monosodium salt} was used to cause color reaction, and the absorbance (OD) at a wavelength *** was measured with a spectrophotometer. In this measuring method, the absorbance and the number of cells are linearly proportional. Since Comparatives 2 to 4 are sparingly soluble in water, experiments were conducted at a concentration at the solubility limit.

【0021】以上の結果を表2に示す。 表2 試料 濃度(ppm) OD値 有意差検定 マロニルダイジン 3×10-5 0.371 * (本発明) 3×10-4 0.358 * 3×10-3 0.377 * 3×10-2 0.397 * 3×10-1 0.367 3 0.321 3×10 0.312 マロニルゲニスチン 3×10-5 0.414 * (本発明) 3×10-4 0.418 ** 3×10-3 0.408 * 3×10-2 0.347 3×10-1 0.334 3 0.314 3×10 0.328 ダイジン 3×10-5 0.300 (比較1) 3×10-4 0.313 3×10-3 0.293 3×10-2 0.298 3×10-1 0.315 3 0.306 3×10 0.312 ゲニスチン 3×10-5 0.350 (比較2) 3×10-4 0.330 3×10-3 0.341 3×10-2 0.327 3×10-1 0.328 3 0.320 ダイゼイン 3×10-5 0.312 (比較3) 3×10-4 0.306 3×10-3 0.293 1×10-2 0.284 2×10-2 0.246 3×10-2 0.209 ゲニステイン 3×10-5 0.343 (比較4) 3×10-4 0.302 3×10-3 0.329 1×10-2 0.318 2×10-2 0.198 3×10-2 0.071 水(対照) 0.315 濃度(ppm):細胞培養液中濃度を示す OD値:5回の繰り返し試験の平均値である。 有意差検定 *:5%危険率で有意差有り **:1%危険率で有意差有り また水を用いたとき(対照)の増殖活性を1とし、それ
ぞれの試料の増殖活性を図1に示した。
The above results are shown in Table 2. Table 2 Sample concentration (ppm) OD value Significant difference test Malonyl daidzin 3 × 10 −5 0.371 * (invention) 3 × 10 −4 0.358 * 3 × 10 −3 0.377 * 3 × 10 −2 0.397 * 3 × 10 −1 0.367 3 0.321 3 × 10 0.312 Malonyl genistin 3 × 10 −5 0.414 * (invention) 3 × 10 −4 0.418 ** 3 × 10 -3 0.408 * 3 x 10 -2 0.347 3 x 10 -1 0.334 3 0.314 3 x 10 0.328 Daihatsu 3 x 10 -5 0.300 (Comparison 1) 3 x 10 -4 0.313 3x10 -3 0.293 3x10 -2 0.298 3x10 -1 0.315 3 0.306 3x10 0.312 Genistin 3x10 -5 0.350 (Comparison 2) 3 × 10 -4 0.330 3 × 10 -3 0.341 3 × 10 -2 0.327 3 × 10 -1 0.32 3 0.320 daidzein 3 × 10 -5 0.312 (Comparative 3) 3 × 10 -4 0.306 3 × 10 -3 0.293 1 × 10 -2 0.284 2 × 10 -2 0.246 3 X10 -2 0.209 genistein 3x10 -5 0.343 (comparative 4) 3x10 -4 0.302 3x10 -3 0.329 1x10 -2 0.318 2x10 -2 0 198 3 × 10 -2 0.071 Water (control) 0.315 Concentration (ppm): Indicates concentration in cell culture solution OD value: Average value of 5 repeated tests. Significant difference test *: Significant difference at 5% risk rate **: Significant difference at 1% risk rate Moreover, the proliferative activity when water was used (control) was set to 1, and the proliferative activity of each sample is shown in FIG. Indicated.

【0022】表2及び図1から明らかなように、マロニ
ルイソフラボン配糖体であるマロニルダイジン、マロニ
ルゲニスチンを3×10-5〜3×10-1ppm添加した
試料はヒト上皮細胞増殖効果を示し、特にマロニルダイ
ジンは添加量3×10-5〜3×10-2ppm、マロニル
ゲニスチンは3×10-5〜3×10-3ppmの範囲で、
有意に効果のあることが認められた。
As is apparent from Table 2 and FIG. 1, the samples containing malonyldaididine and malonylgenistin, which are malonyl isoflavone glycosides, added at 3 × 10 -5 to 3 × 10 -1 ppm show human epithelial cell proliferation effect. particularly malonyldaidzin addition amount 3 × 10 -5 ~3 × 10 -2 ppm, malonylgenistin in the range of 3 × 10 -5 ~3 × 10 -3 ppm,
It was confirmed to be significantly effective.

【0023】また生理活性作用があるとされるダイジ
ン、ゲニスチン、ダイゼイン、ゲニステイン(比較1〜
4)においては、ダイジン、ゲニスチンは効果が認めら
れたが有意な効果でなく、またダイゼイン、ゲニステイ
ンではほとんど効果が認められず、高い濃度では阻害が
認められた。
Also, daidzin, genistin, daidzein, genistein (Comparative 1
In 4), the effects of daidzin and genistin were recognized, but the effects were not significant, and the effects of daidzein and genistein were hardly observed, and inhibition was observed at high concentrations.

【0024】[0024]

【実施例】以下に実施例を示す。 実施例1 脱皮大豆の温水抽出液20Lを、塩酸でpH4.0に調整
し2時間放置後、濾過助剤(ラジオライト#500、昭
和化学製)を添加し、ブフナーロートで吸引濾過した。
この濾液を活性炭(精製白鷺クロマト用、武田薬品工業
製)を充填したカラム(5×22cm、430ml)に1.
5L/hrの流速で通液させてマロニルイソフラボン配糖体
を吸着させた後、1%アンモニア水3Lでカラムを洗浄
した。次いで1%アンモニア含有50%エタノール水溶
液5Lで溶出し、得られた溶出液を減圧下、50℃で濃
縮し、マロニルダイジン1.23g、マロニルゲニスチ
ン1.05gを含有する濃縮液500mlを得た。この濃
縮液を2NのカセイソーダでpH8.0としODS樹脂充
填カラム(4×24cm、300ml)に流速30ml/min.
で通液し、蒸留水0.5Lで洗浄後、2%、5%及び1
0 %エタノール水溶液各2Lで溶出を行い、5%エタノ
ール水溶液の溶出区分よりマロニルダイジン画分を、1
0%エタノール水溶液の溶出区分よりマロニルゲニスチ
ン画分を得、それぞれを減圧下、50℃で減圧濃縮した
後、凍結乾燥し、マロニルダイジンをナトリウム塩とし
て652mg、マロニルゲニスチンをナトリウム塩として
412mg得た。こうして得られたマロニルダイジンナト
リウム塩又はマロニルゲニスチンナトリウム塩を上皮細
胞増殖因子として以下の皮膚用剤を調整した。
Examples are shown below. Example 1 20 L of the hot water extract of dehulled soybeans was adjusted to pH 4.0 with hydrochloric acid and allowed to stand for 2 hours, then a filter aid (Radiolite # 500, Showa Kagaku) was added, and suction filtration was carried out using a Buchner funnel.
This filtrate was applied to a column (5 × 22 cm, 430 ml) packed with activated carbon (for purified Shirasagi chromatography, manufactured by Takeda Pharmaceutical Co., Ltd.).
The solution was passed at a flow rate of 5 L / hr to adsorb malonyl isoflavone glycoside, and then the column was washed with 3 L of 1% ammonia water. Then, elution was carried out with 5 L of a 50% aqueous ethanol solution containing 1% ammonia, and the obtained eluate was concentrated at 50 ° C. under reduced pressure to obtain 500 ml of a concentrated solution containing 1.23 g of malonyldaididine and 1.05 g of malonylgenistin. The concentrated solution was adjusted to pH 8.0 with 2N caustic soda, and the flow rate was 30 ml / min in an ODS resin packed column (4 × 24 cm, 300 ml).
After washing with 0.5 L of distilled water, 2%, 5% and 1
Elute with 2 L each of 0% ethanol aqueous solution, and extract the malonyldaidine fraction from the elution fraction of 5% ethanol aqueous solution to 1 L.
Malonylgenistin fractions were obtained from the elution fraction of a 0% ethanol aqueous solution, concentrated under reduced pressure at 50 ° C. under reduced pressure, and then freeze-dried to obtain 652 mg of malonyldaidinidine as a sodium salt and 412 mg of malonylgenistin as a sodium salt. Using the malonyl daidzin sodium salt or malonyl genistin sodium salt thus obtained as an epidermal growth factor, the following skin preparations were prepared.

【0025】<皮膚化粧剤> マロニルダイジン−Na 1 マロニルゲニスチン−Na 1 エタノール 80 グリセリン 45 ポリオキシエチレン硬化ヒマシ油 5 香料 1 精製水 867 これらを混合し皮膚化粧剤とした。<Skin cosmetic agent> Malonyl daidzin-Na 1 Malonyl genistin-Na 1 Ethanol 80 Glycerin 45 Polyoxyethylene hydrogenated castor oil 5 Perfume 1 Purified water 867 These were mixed to prepare a skin cosmetic agent.

【0026】<皮膚外用剤>親水軟膏基剤(小堺製薬
製)1kgにマロニルダイジン−Na及びマロニルゲニ
スチン−Naを各200mgずつ精製水200mlに溶
解後混和して皮膚外用剤とした。
<External skin preparation> Malonyldaididine-Na and malonylgenistin-Na (200 mg each) were dissolved in 1 kg of a hydrophilic ointment base (manufactured by Kosakai Pharmaceutical Co., Ltd.) in 200 ml of purified water and mixed to prepare an external skin preparation.

【0027】<育毛剤>8%エタノール溶液1lにマロ
ニルダイジン−Na及びマロニルゲニスチン−Naを各
2mg溶解して育毛剤とした。
<Hair Growth Agent> Malonyl daidzin-Na and malonyl genistin-Na (2 mg each) were dissolved in 1 liter of an 8% ethanol solution to prepare a hair growth agent.

【0028】<使用例1>上記した<皮膚化粧剤>を5
0代の女性20名に1ヵ月間使用させ、アンケート調査
したところ、15名のパネルから皮膚のはりに効果があ
り、内10名はしわの防止に効果があるという回答を得
た。また残りの5名も肌がしっとりとしたとの回答があ
った。
<Use Example 1> 5% of the above <skin cosmetic agent>
When 20 women in their 0's were allowed to use it for 1 month and a questionnaire survey was conducted, a panel of 15 people answered that it was effective for skin scalp and 10 of them were effective in preventing wrinkles. The remaining 5 respondents also said that their skin was moisturized.

【0029】<使用例2>肌あれ症(乾燥肌)の20〜
40代の女性10名に1ヵ月間、右手に上記、〈皮膚外
用剤>を、左手にはコントロールとしてマロニル配糖体
無添加の軟膏を、毎日就寝前に塗布してもらい、その後
左右の手の肌あれ症状の状態を観察してもらったとこ
ろ、10名とも右手の方がしっとりと滑らかとなり、肌
あれの治癒効果を認めた。
<Use Example 2> 20 for skin roughness (dry skin)
10 females in their 40s were asked to apply the above-mentioned <skin external preparation> to their right hands for one month, and to their left hands a malonyl glycoside-free ointment as a control every day before bedtime, and then on their left and right hands. As a result of observing the condition of skin roughening, the 10 hands showed that the right hand became smoother and smoother, and the healing effect of the skin roughening was recognized.

【0030】<使用例3>上記〈育毛剤〉を50代の男
性10名に1ヵ月間、洗髪後頭皮に使用してもらったと
ころ6名が髪に艶が出、抜け毛が減ったとの効果を認め
た。
<Use Example 3> When 10 males in their 50's were used on the scalp after washing the hair for 1 month with the above <Hair growing agent>, the effect was that 6 of them had shiny hair and reduced hair loss. Admitted.

【0031】[0031]

【発明の効果】本発明はマロニルイソフラボン配糖体が
上皮細胞増殖因子として作用し、上皮細胞増殖促進に効
果があるという知見に基づくものであり、これにより皮
膚の老化防止、肌あれ改善等の皮膚化粧剤、抗炎症剤、
創傷治療剤等として有用な皮膚外用剤等を提供すること
ができる。
INDUSTRIAL APPLICABILITY The present invention is based on the finding that malonyl isoflavone glycoside acts as an epithelial cell growth factor and is effective in promoting epithelial cell growth, whereby it is possible to prevent skin aging, improve skin roughness, etc. Skin cosmetics, anti-inflammatory agents,
It is possible to provide a skin external preparation and the like useful as a wound treatment agent and the like.

【図面の簡単な説明】[Brief description of drawings]

【図1】正常ヒト皮膚上皮細胞に対する、各試料の増殖
活性を示す。
FIG. 1 shows the proliferative activity of each sample on normal human skin epithelial cells.

───────────────────────────────────────────────────── フロントページの続き (72)発明者 小幡 明雄 千葉県野田市野田339番地 キッコーマン 株式会社内 (72)発明者 山次 信幸 千葉県野田市野田339番地 キッコーマン 株式会社内 (72)発明者 戸辺 光一朗 千葉県野田市野田339番地 キッコーマン 株式会社内 ─────────────────────────────────────────────────── ─── Continuation of the front page (72) Inventor Akio Obata 339 Noda, Noda, Chiba Prefecture, Kikkoman Corporation (72) Inventor Nobuyuki Yamaji 339 Noda, Noda, Chiba Prefecture, Kikkoman Corporation (72) Inventor, Tobe Koichiro 339 Noda, Noda City, Chiba Prefecture Kikkoman Corporation

Claims (4)

【特許請求の範囲】[Claims] 【請求項1】 マロニルイソフラボン配糖体を有効成分
とする上皮細胞増殖促進剤。
1. An epithelial cell growth promoter containing malonyl isoflavone glycoside as an active ingredient.
【請求項2】 マロニルイソフラボン配糖体を含有させ
た皮膚用剤。
2. A skin agent containing malonyl isoflavone glycoside.
【請求項3】 マロニルイソフラボン配糖体が、大豆又
は大豆の水抽出液から取得したものである請求項1又は
2記載の皮膚用剤。
3. The dermatological agent according to claim 1 or 2, wherein the malonyl isoflavone glycoside is obtained from soybean or an aqueous extract of soybean.
【請求項4】 皮膚用剤が皮膚化粧剤、育毛剤、皮膚外
用剤、抗炎症剤のいずれかである請求項2記載の皮膚用
剤。
4. The dermatological agent according to claim 2, which is one of a skin cosmetic agent, a hair-growth agent, a skin external agent and an anti-inflammatory agent.
JP23068295A 1995-08-17 1995-08-17 Epithelial cell growth promoter Expired - Fee Related JP3302535B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP23068295A JP3302535B2 (en) 1995-08-17 1995-08-17 Epithelial cell growth promoter

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP23068295A JP3302535B2 (en) 1995-08-17 1995-08-17 Epithelial cell growth promoter

Publications (2)

Publication Number Publication Date
JPH0959166A true JPH0959166A (en) 1997-03-04
JP3302535B2 JP3302535B2 (en) 2002-07-15

Family

ID=16911665

Family Applications (1)

Application Number Title Priority Date Filing Date
JP23068295A Expired - Fee Related JP3302535B2 (en) 1995-08-17 1995-08-17 Epithelial cell growth promoter

Country Status (1)

Country Link
JP (1) JP3302535B2 (en)

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6093411A (en) * 1998-03-16 2000-07-25 The Procter & Gamble Company Compositions for regulating skin appearance
JP2000302667A (en) * 1999-04-23 2000-10-31 Kobe Tennenbutsu Kagaku Kk Accelerator for ample breasts
US6479054B1 (en) 1998-09-21 2002-11-12 Showa Sangyo Co., Ltd. Process for obtaining genistin-rich isoflavone composition
WO2003000674A1 (en) * 2001-06-21 2003-01-03 Fuji Oil Company,Limited Process for producing soluble isoflavone-containing composition
EP1074240A3 (en) * 1999-07-27 2003-01-29 JOHNSON &amp; JOHNSON CONSUMER PRODUCTS, INC. Reducing hair growth, hair follicle and hair shaft size and hair pigmentation
US7112344B2 (en) 2003-08-11 2006-09-26 I-Hung Chu Vapor fraction from seeds of Glycine max (L.)Merr. and composition thereof
JP2007008908A (en) * 2005-07-04 2007-01-18 Takahito Tokuyama Cell proliferation enhancer and cell-repairing agent using cereals except rice or pulse crops as raw material
WO2007086327A1 (en) * 2006-01-24 2007-08-02 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Dermal papilla cell growth promoter
US7282226B2 (en) 2003-08-11 2007-10-16 I-Hung Chu Vapor fraction from seeds of Glycine max (L.) Merr. and composition thereof
JP2009242324A (en) * 2008-03-31 2009-10-22 Naris Cosmetics Co Ltd Keratinocyte proliferation promoter
JP2010150203A (en) * 2008-12-25 2010-07-08 Lion Corp Hair growing agent composition
US7897144B2 (en) 2001-02-28 2011-03-01 Johnson & Johnson Comsumer Companies, Inc. Compositions containing legume products
AU2008212016B2 (en) * 1999-07-27 2011-11-17 Johnson & Johnson Consumer Companies, Inc. Reducing hair growth, hair follicle and hair shaft size and hair pigmentation
US8093293B2 (en) 1998-07-06 2012-01-10 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin conditions
US8106094B2 (en) 1998-07-06 2012-01-31 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for treating skin conditions
US8431550B2 (en) 2000-10-27 2013-04-30 Johnson & Johnson Consumer Companies, Inc. Topical anti-cancer compositions and methods of use thereof

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6093411A (en) * 1998-03-16 2000-07-25 The Procter & Gamble Company Compositions for regulating skin appearance
US8106094B2 (en) 1998-07-06 2012-01-31 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for treating skin conditions
US8093293B2 (en) 1998-07-06 2012-01-10 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin conditions
US6479054B1 (en) 1998-09-21 2002-11-12 Showa Sangyo Co., Ltd. Process for obtaining genistin-rich isoflavone composition
JP2000302667A (en) * 1999-04-23 2000-10-31 Kobe Tennenbutsu Kagaku Kk Accelerator for ample breasts
US7985404B1 (en) * 1999-07-27 2011-07-26 Johnson & Johnson Consumer Companies, Inc. Reducing hair growth, hair follicle and hair shaft size and hair pigmentation
AU2008212016B2 (en) * 1999-07-27 2011-11-17 Johnson & Johnson Consumer Companies, Inc. Reducing hair growth, hair follicle and hair shaft size and hair pigmentation
EP1074240A3 (en) * 1999-07-27 2003-01-29 JOHNSON &amp; JOHNSON CONSUMER PRODUCTS, INC. Reducing hair growth, hair follicle and hair shaft size and hair pigmentation
US8431550B2 (en) 2000-10-27 2013-04-30 Johnson & Johnson Consumer Companies, Inc. Topical anti-cancer compositions and methods of use thereof
US7897144B2 (en) 2001-02-28 2011-03-01 Johnson & Johnson Comsumer Companies, Inc. Compositions containing legume products
WO2003000674A1 (en) * 2001-06-21 2003-01-03 Fuji Oil Company,Limited Process for producing soluble isoflavone-containing composition
US7282226B2 (en) 2003-08-11 2007-10-16 I-Hung Chu Vapor fraction from seeds of Glycine max (L.) Merr. and composition thereof
US7112344B2 (en) 2003-08-11 2006-09-26 I-Hung Chu Vapor fraction from seeds of Glycine max (L.)Merr. and composition thereof
JP2007008908A (en) * 2005-07-04 2007-01-18 Takahito Tokuyama Cell proliferation enhancer and cell-repairing agent using cereals except rice or pulse crops as raw material
WO2007086327A1 (en) * 2006-01-24 2007-08-02 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Dermal papilla cell growth promoter
JP2009242324A (en) * 2008-03-31 2009-10-22 Naris Cosmetics Co Ltd Keratinocyte proliferation promoter
JP2010150203A (en) * 2008-12-25 2010-07-08 Lion Corp Hair growing agent composition

Also Published As

Publication number Publication date
JP3302535B2 (en) 2002-07-15

Similar Documents

Publication Publication Date Title
JP3302535B2 (en) Epithelial cell growth promoter
KR100844516B1 (en) Cosmetic composition containing astragalus root extract
KR101740097B1 (en) Anti-inflammation and Anti-aging composition for skin external application comprising Leontopodium alpinum Cell Culture Extract and Methods for preparing the Same
US8546335B2 (en) Peptidic hydrolyzate proteasome activators and compositions containing same
KR20130088224A (en) Skin external composition containing drumstick tree seed extract
EP0200757A1 (en) Promotion of wound healing with human epidermal growth factor prepared from recombinant dna.
WO2006080768A1 (en) Anti-aging cosmetic composition
KR102509224B1 (en) Fuctional cosmetic composition
CN110731919A (en) Application of Mirabilis jalapa extracts and skin external preparation containing the same
KR20160091301A (en) Brassocattleya marcella koss orchid extract and use thereof as skin depigmentation agent
JP2013053108A (en) Camellia flower extract
KR20080057419A (en) Cosmetic composition for preventing skin aging comprising the morinda citrifolia extract as active ingredient
KR20210074263A (en) Anti-hair loss and hair growth stimulants comprising growth factors and isoflavone
KR101685251B1 (en) Cosmetic composition comprising extract of Brassica Rapa, Brassica Rapa radish leaves or Brassica Rapa callus with anti-oxidant, astringent activity and skin wrinkle improvement effect and the manufacturing method thereof
CN102459309A (en) Proteasome-activating leucitide hydrolysates and compositions containing them
KR100519154B1 (en) Antiageing and whitening cosmetics containing natural extracts
KR102523606B1 (en) Cosmetic composition containing polysaccharide extracted from alfalfa seeds
KR102303815B1 (en) Cosmetic Composition For Enhancing Skin Barrier and moisture Containing Peptides from Chiaseed As Active Ingredient
KR100463081B1 (en) Cosmetic compositions containing Phaseolus aureus extracts for skin whitening
KR20040087644A (en) Cosmetic Composition Comprising Pyrus communis L. Extract for Skin Whitening
CN115038426A (en) Murraya koenigii extract and application thereof in cosmetics
KR20030025067A (en) Composition of cosmetics contains punica extracts
KR20210026550A (en) Cosmetic materials with excellent anti inflammation, antioxidant and skin whitening, Manufacturing method thereof and cosmetics containing the same
KR20020001914A (en) Cosmetics containing Ramulus mori extracts and glutathione for skin whitening
KR102610467B1 (en) Composition for enhancing skin elasticity comprising collagen-like proteins of coffee silver skin and an extract of fermented coffee silver skin and a method for manufacturing the same

Legal Events

Date Code Title Description
S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313117

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090426

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090426

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100426

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110426

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110426

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120426

Year of fee payment: 10

LAPS Cancellation because of no payment of annual fees